News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Sun Pharmaceutical Industries Ltd Announces FDA Approval for Generic Xanax(R) Tablets
June 18, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MUMBAI, India--(BUSINESS WIRE)--Sun Pharma announced that USFDA has granted an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Xanax®, alprazolam tablets.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Asia
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Approvals
GSK Wins Asthma Approval for Anti-Inflammatory Antibody
December 17, 2025
·
2 min read
·
Tristan Manalac
Podcast
Lilly’s Triple Triumph, Prasad’s COVID Error, J&J’s Surprise Voucher, M&A Targets
December 17, 2025
·
2 min read
·
Heather McKenzie
Insights
Uptick in Dealmaking, Chinese Partnerships Drive Biotech’s Comeback
December 17, 2025
·
3 min read
·
Jennifer Smith-Parker
Vaccines
Makary Denies FDA Plans To Levy Black Box Warning on COVID-19 Vaccines
December 16, 2025
·
3 min read
·
Heather McKenzie